AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3
slide-4

Nobegliz-M XR Tablet

Prescription Icon
Prescription Required

Marketer

Mankind Pharma Ltd

Salt Composition

Gliclazide (60mg) + Metformin (500mg)

Overview Nobegliz-M XR Tablet

Diabexe Duo XR tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by managing blood glucose levels. Diabexe Duo XR should be taken with meals, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on your blood glucose response. Continued use is crucial, even with well-controlled blood sugar, as abrupt cessation can lead to elevated glucose, potentially causing kidney complications, vision impairment, neuropathy, and limb loss. This medication is part of a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle modifications are essential for diabetes control. Common side effects include hypoglycemia (low blood sugar), characterized by sweating, dizziness, headache, and tremors; constipation; and vomiting. Regular meals and readily available glucose sources (e.g., sugary snacks or juice) are vital to manage hypoglycemia. Alcohol should be avoided due to its potential to exacerbate low blood sugar. Additional possible side effects are altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before starting treatment. Pregnant or lactating individuals require physician consultation. Regular blood glucose monitoring, along with blood counts and liver function tests as advised by your doctor, are necessary.

Uses of Nobegliz-M XR Tablet

Adult-onset diabetes

Major Benefits of Nobegliz-M XR Tablet:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Administer Nobegliz-M XR Tablet with food.

Common Side effects of Nobegliz-M XR Tablet:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Dizziness
  • Diarrhea
  • Upper respiratory tract infection
  • Nausea
  • Flatulence
  • Constipation

How to use Nobegliz-M XR Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Nobegliz-M XR Tablet with a meal.

How Nobegliz-M XR Tablet works:

Nobegliz-M XR Tablet contains Gliclazide and Metformin, two medications used to manage blood sugar levels.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking Nobegliz-M XR Tablet is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Nobegliz-M XR tablets during pregnancy poses a confirmed risk to the fetus. Prescribing may occur in exceptional, life-threatening circumstances where potential benefits outweigh risks, but only at the discretion of a physician. Always seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Nobegliz-M XR Tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Exercise caution when administering Nobegliz-M XR Tablets to individuals with impaired kidney function; dosage modification may be necessary. Consult a physician for guidance. Nobegliz-M XR Tablets are contraindicated in patients exhibiting severe kidney disease. Routine monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Exercise caution when prescribing Nobegliz-M XR tablets to individuals with hepatic impairment. Dosage modification may be necessary. Physician consultation is advised. For patients exhibiting mild to moderate liver dysfunction, initiate Nobegliz-M XR Tablet therapy at a reduced dosage; its use is contraindicated in those with severe liver disease.

What if you forget to take Nobegliz-M XR Tablet :

Should you forget a Nobegliz-M XR Tablet dose, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Nobegliz-M XR Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Nobegliz-M XR Tablet

Nobegliz-M XR tablets combine gliclazide and metformin to manage type 2 diabetes mellitus (DM) in adults. This combination, used alongside diet and exercise, improves blood glucose control. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 DM.
Nobegliz-M XR Tablet may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infection. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Nobegliz-M XR Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Therefore, regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice to treat low blood sugar.
Nobegliz-M XR Tablets can cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a serious medical emergency resulting from excessive blood lactic acid. This rare side effect is preventable by avoiding use in patients with kidney disease, older adults, or those who consume large amounts of alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Nobegliz-M XR and seek immediate medical attention.
Prolonged Nobegliz-M XR Tablet use can lead to vitamin B12 deficiency by interfering with its stomach absorption. This deficiency, if left untreated, may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate this risk, supplemental vitamin B12 is recommended at least annually by some researchers.
Nobegliz-M XR Tablets are contraindicated in patients with allergies to any ingredient or excipient, and in those with moderate-to-severe kidney disease or metabolic acidosis, including diabetic ketoacidosis.
Combining Nobegliz-M XR tablets and alcohol is unsafe. Alcohol can worsen hypoglycemia and raise the risk of lactic acidosis.
Nobegliz-M XR tablets combine gliclazide and metformin to manage type 2 diabetes mellitus in adults. This medication improves blood sugar control when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Nobegliz-M XR Tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Yes, Nobegliz-M XR Tablets can lower blood sugar levels (cause hypoglycemia). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and shakiness or anxiety. This risk increases if you skip meals, drink alcohol, overexert yourself, or take other diabetes medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Nobegliz-M XR Tablets can cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a serious medical emergency resulting from excessive blood lactic acid. This rare side effect is preventable by avoiding use in patients with kidney disease, the elderly, or those consuming significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Nobegliz-M XR and seek immediate medical attention.
Prolonged Nobegliz-M XR Tablet use can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left unaddressed, may result in anemia, neurological issues such as tingling, numbness in the extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, supplemental vitamin B12 is recommended at least annually by some researchers.
Nobegliz-M XR Tablets are contraindicated in patients with known allergies to any ingredient or excipient. They should also be avoided in individuals with moderate to severe kidney disease or metabolic acidosis, including diabetic ketoacidosis.
Combining Nobegliz-M XR tablets and alcohol is unsafe. Alcohol can worsen hypoglycemia and raise the risk of lactic acidosis.
Nobegliz-M XR Tablet
81
MRP 99
18% off